期刊文献+

清热解毒软胶囊抑菌抗炎作用实验研究 被引量:4

Experimental Study on Bacteriostasis and Anti-inflammatory Effects of QingRenJeDuJiaoNang
下载PDF
导出
摘要 目的研究清热解毒软胶囊的抑菌、抗炎作用。方法呼吸道常见致病菌用肉汤稀释法测定清热解毒软胶囊最低抑菌浓度(M IC);用蛋清诱发大鼠足肿胀、二甲苯诱发小鼠耳肿胀等急性炎症模型和大鼠棉球肉芽肿慢性炎症模型研究抗炎作用。结果清热解毒软胶囊具有体外抗菌作用,对引起呼吸道感染的9种常见病原菌和致病菌均有不同程度的抑制作用;清热解毒软胶囊具有抗炎作用,对二甲苯致小鼠耳廓肿胀、大鼠蛋清性足肿胀及大鼠棉球肉芽肿均有不同程度的抑制作用。结论本研究结果提示清热解毒软胶囊具有抑菌、抗炎作用,为清热解毒软胶囊临床用于治疗流感、上呼吸道感染、咽喉肿痛等症提供了实验参考依据。 Objective To observe the bacteriostasis and anti - inflammatory effect as of QingReJeDuJiaoNang. Methods The test checkerboard dilution was used to examine the MIC of 9 kinds of common bacteria. The anti - inflammatory effect was observed by auricular edema model induced by dimethylbenzene in mice, granulation induced by cotton ball in rats, metatarsus swelling model induced by egg white in rats. Results QingReJeDuJiaoNang had bacteriostasis effect to 9 kinds of familiar bacteria causing respiratory system infection. Furthermore, QingReJeDuJiaoNang significantly inhibited auricular edema induced by dimcthylbenzene in mice, granulation induced by cotton ball in rats, and metatarsus swelling induced by egg white in rats. Conclusion QingReJeDuJiaoNang had bacteriostasis and anti - inflammatory effect.
作者 郭芹 杨光义
出处 《时珍国医国药》 CAS CSCD 北大核心 2009年第3期700-702,共3页 Lishizhen Medicine and Materia Medica Research
关键词 清热解毒软胶囊 抑菌 抗炎 QingRenJeDuJiaoNang Bacteriostasis Anti - inflammation
  • 相关文献

参考文献4

二级参考文献22

  • 1熊礼宽,杨应周,王仕洪,林振南.氧氟沙星和环丙沙星对快速生长分支杆菌最低抑菌浓度测定[J].中国防痨杂志,1995,17(1):24-25. 被引量:6
  • 2CW迪芬巴赫 G S 德维克斯勒著.PCR技术实验指南[M].北京:科学出版社,2003.105-113.
  • 3Prammananan T, Sander P, Springer B, et al. RecA-mediated gene conversion and aminoglycoside resistance in strains heterozygous for rRNA.Antimicrobial Agent and Chemotherapy, 1999, 43(3): 447-453.
  • 4Hegde SS, Dam TK, Brewer CF. Thermodynamics of aminoglycoside and acyl-coenzyme a binding to the Salmonella enterica AAC(6')- Ⅰ y aminoglycoside N-acetyltransferase. Biochemistry, 2002, 41 (23): 7519-7527.
  • 5Mingeot-Leclercq MP, Glupczynski Y, Tulkens PM. Aminoglycosides:activity and resistance. Antimicrobial Agent and Chemotherapy, 1999,43(4): 727-737.
  • 6Shaw K J, Rather P N, Hare RS, et al. Molecular genetics ofaminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiological Reviews, 1993, 57(1): 138-163.
  • 7Vandepitte J, Engbaek K, Piot P, et al. Basic Laboratory Procedures in Clinical Bacteriology. World Health Organization, Geneva, 1991.
  • 8Ferraro MJ, Craig WA, Dudley MN, et al. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard-Seventh Edition. NCCLS, 2000, 20(1): M2-A7.
  • 9Wikler MA, Cockerill FR, Craig WA, et al. Performance Standards for Antimicrobial Disk Susceptibility Tests; Twelfth Informational Supplement. NCCLS, 2004, 24(1): M100-S14.
  • 10Neonakis I, Gikas A, Scoulica E, et al. Evolution of aminoglycoside resistance phenotypes of four Gram-negative bacteria: an 8-year survey in a University Hospital in Greece. International Journal of Antimicrobial Agent, 2003, 22(5): 526-531.

共引文献30

同被引文献40

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部